Differences in education, knowledge, self-management activities, and health outcomes for patients with heart failure cared for under the chronic disease model: the improving chronic illness care evaluation.

Abstract:

BACKGROUND:The objective of this study was to determine whether participation in a quality improvement (QI) collaborative for heart failure (HF) was associated with better interpersonal aspects of care and health outcomes. METHODS AND RESULTS:We conducted a cross-sectional telephone survey of patients in 6 organizations who participated in a QI collaborative for HF (participants, n = 387) and 6 comparable control organizations (controls, n = 414) and measured provider-patient communication, education received, knowledge of HF, self-management behaviors, satisfaction, and quality of life. The participant group patients were more likely to report their doctor and nurse discussed treatment options and reviewed self-management (P < .01 for both). A total of 88% of participants were told to weigh themselves daily and record their weight compared with 34% of controls (P < .01). Participants were more likely to know how often to check their weight (P < .01), recognize symptoms of worsening HF (P < or = .01 for all), have a scale (P = .002), and monitor their weight daily (P < .001). Participants had similar quality of life but fewer emergency department visits and hospitalizations. CONCLUSION:Participation in a QI collaborative for HF was associated with better communication, education, and knowledge, and lower health care use. Collaboratives may be a useful method for disseminating quality improvement strategies.

journal_name

J Card Fail

authors

Baker DW,Asch SM,Keesey JW,Brown JA,Chan KS,Joyce G,Keeler EB

doi

10.1016/j.cardfail.2005.03.010

keywords:

subject

Has Abstract

pub_date

2005-08-01 00:00:00

pages

405-13

issue

6

eissn

1071-9164

issn

1532-8414

pii

S1071-9164(05)00137-5

journal_volume

11

pub_type

杂志文章
  • Association between prehospital delay and subsequent clinical course in patients with/hospitalized for heart failure.

    abstract:BACKGROUND:The clinical consequences of prehospital delay in heart failure (HF) patients are unknown. This study explores the relationship between prehospital delay of HF patients and length of hospital stay, plasma values of brain natriuretic peptides (BNP) as well as the association of delay with all-cause mortality,...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2011.12.007

    authors: Johansson P,van der Wal M,van Veldhuisen DJ,Jaarsma T

    更新日期:2012-03-01 00:00:00

  • Noninvasive monitoring of left ventricular end-diastolic pressure reduces rehospitalization rates in patients hospitalized for heart failure: a randomized controlled trial.

    abstract:BACKGROUND:In patients admitted for heart failure (HF), unrecognized elevation of left ventricular end-diastolic pressure (LVEDP) at the time of discharge may have a role in the high rehospitalization rate for HF on follow-up. METHODS AND RESULTS:In a small, prospective study (n = 50), patients admitted for HF were ra...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2011.04.014

    authors: Sharma GV,Woods PA,Lindsey N,O'Connell C,Connolly L,Joseph J,McIntyre KM

    更新日期:2011-09-01 00:00:00

  • Improvement of guideline β-blocker prescribing in heart failure: a cluster-randomized pragmatic trial of a pharmacy intervention.

    abstract:BACKGROUND:Treatment with specific beta-blockers and doses recommended by guidelines is often not achieved in practice. We evaluated an intervention directed to the pharmacy to improve prescribing. METHODS AND RESULTS:We conducted a pragmatic cluster-randomized trial, where facilities (n = 12) with patients (n = 220) ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2013.06.004

    authors: McCarren M,Furmaga E,Jackevicius CA,Sahay A,Coppler TL,Katzianer J,Griffiths RL,Tonnu-Mihara I,Heidenreich P

    更新日期:2013-08-01 00:00:00

  • Sacubitril/Valsartan Therapy Ameliorates Ventricular Tachyarrhythmia Inducibility in a Rabbit Myocardial Infarction Model.

    abstract:BACKGROUND:Coronary artery disease is the most common cause of heart failure (HF) in developed countries. The aim of this study was to elucidate the mechanisms of reduction of arrhythmias after sacubitril/valsartan (LCZ696) therapy in a myocardial infarction (MI)-HF rabbit model. METHODS AND RESULTS:Chronic MI in rabb...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.03.007

    authors: Chang PC,Wo HT,Lee HL,Lin SF,Chu Y,Wen MS,Chou CC

    更新日期:2020-06-01 00:00:00

  • Elevated Heart Rate Following Heart Transplantation Is Associated With Increased Graft Vasculopathy and Mortality.

    abstract:BACKGROUND:The effect of elevated heart rate (HR) on outcomes after heart transplantation (HT) has not been well established. The aim of this study was to assess predictors of elevated HR following HT and its impact on outcomes. METHODS AND RESULTS:We retrospectively evaluated 394 patients who underwent HT at 2 academ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2019.01.009

    authors: Liebo M,Newman J,Joshi A,Lowes BD,Peled-Potashnik Y,Basha HI,Zolty R,Um JY,McGee E Jr,Heroux A,Raichlin E

    更新日期:2019-04-01 00:00:00

  • Aldosterone stimulates angiotensin-converting enzyme expression and activity in rat neonatal cardiac myocytes.

    abstract:BACKGROUND:Members of the nuclear receptor family proteins function as transcription factors upon ligand binding and thereby regulate gene expression in host cells. Aldosterone, the high-affinity endogenous ligand for the mineralocorticoid receptor, induces cardiac hypertrophy and fibrosis in a variety of animal models...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1054/jcaf.2002.125369

    authors: Wang J,Yu L,Solenberg PJ,Gelbert L,Geringer CD,Steinberg MI

    更新日期:2002-06-01 00:00:00

  • Aortic Insufficiency During HeartMate 3 Left Ventricular Assist Device Support.

    abstract:BACKGROUND:Aortic insufficiency (AI) is associated with morbidity and mortality in patients with continuous-flow left ventricular assist devices (LVADs), whereas its impact on the HeartMate 3 LVAD cohorts remains uninvestigated. We aimed to investigate the clinical impact of AI on patients with HeartMate 3 LVADs. METH...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2020.05.013

    authors: Imamura T,Narang N,Kim G,Nitta D,Fujino T,Nguyen A,Grinstein J,Rodgers D,Ota T,Jeevanandam V,Sayer G,Uriel N

    更新日期:2020-10-01 00:00:00

  • Carvedilol improves left atrial and left ventricular function and reserve in dilated cardiomyopathy after 1 year of treatment.

    abstract:BACKGROUND:The aim of this study was to evaluate the effects of carvedilol therapy on left atrial (LA) function in patients with heart failure from nonischemic dilated cardiomyopathy. METHODS AND RESULTS:Thirty-five patients (42.4 +/- 13.5 years) in New York Heart Association functional Class II-III have been studied....

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2006.10.011

    authors: Paraskevaidis I,Farmakis D,Parissis JT,Dodouras T,Filippatos G,Tsiapras D,Kremastinos DT

    更新日期:2007-03-01 00:00:00

  • Influence of Risk on Reduction of Readmission and Death by Disease Management Programs in Heart Failure.

    abstract:OBJECTIVE:Disease management programs (DMPs) may reduce short-term readmission or death after heart failure (HF) hospitalization. We sought to determine if targeting of DMP to the highest-risk patients could improve efficiency. METHODS AND RESULTS:Patients (n = 412) admitted with HF were randomized to usual care or an...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1016/j.cardfail.2019.01.015

    authors: Huynh QL,Whitmore K,Negishi K,Marwick TH,ETHELRED Investigators.

    更新日期:2019-05-01 00:00:00

  • Low-to-moderate alcohol intake and health status in heart failure patients.

    abstract:BACKGROUND:Although heart failure (HF) guidelines recommend alcohol abstinence, existing evidence indicates that alcohol may not worsen survival and no data about associations between alcohol and health status (patients' symptoms, function, and quality of life) exist. METHODS AND RESULTS:Alcohol use was quantified in ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2004.11.009

    authors: Salisbury AC,House JA,Conard MW,Krumholz HM,Spertus JA

    更新日期:2005-06-01 00:00:00

  • Effects of bisoprolol and losartan treatment in the hypertrophic and failing right heart.

    abstract:BACKGROUND:Sympathetic adrenergic stimulation and the renin-angiotensin-aldosterone system are highly elevated in right heart failure. We evaluated if treatment with the adrenergic receptor blocker bisoprolol or the angiotensin II receptor blocker losartan could prevent the progression of right ventricular (RV) hypertr...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2014.08.003

    authors: Andersen S,Schultz JG,Andersen A,Ringgaard S,Nielsen JM,Holmboe S,Vildbrad MD,de Man FS,Bogaard HJ,Vonk-Noordegraaf A,Nielsen-Kudsk JE

    更新日期:2014-11-01 00:00:00

  • The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure.

    abstract::Propionyl-L-carnitine (PLC) is a naturally occurring compound that has been considered for the treatment of congestive heart failure (CHF). The rationale for its use in this pathology is related to its effects on cardiac and skeletal muscle. Chronic treatment with PLC improves the contraction of isolated and aerobic p...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1016/s1071-9164(97)90018-x

    authors: Ferrari R,De Giuli F

    更新日期:1997-09-01 00:00:00

  • The dog model of left ventricular remodeling after myocardial infarction.

    abstract:BACKGROUND:For over a century, the dog model has been used widely in research studying cardiovascular physiology pertinent to humans. It has been specially applied, over the past 2 decades, in research on the pathophysiology and treatment of left ventricular (LV) remodeling and heart failure. METHODS AND RESULTS:Becau...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,评审

    doi:10.1054/jcaf.2002.129274

    authors: Jugdutt BI

    更新日期:2002-12-01 00:00:00

  • A synthetic non-degradable polyethylene glycol hydrogel retards adverse post-infarct left ventricular remodeling.

    abstract:BACKGROUND:Left ventricular remodeling after myocardial infarction is a key component of heart failure and it has long been postulated that it may result from increased wall stress. It has recently been suggested that an injectable, non-degradable polymer may limit pathological remodeling in a manner analogous to that ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.03.003

    authors: Dobner S,Bezuidenhout D,Govender P,Zilla P,Davies N

    更新日期:2009-09-01 00:00:00

  • Effects of different degrees of sympathetic antagonism on cytokine network in patients with ischemic dilated cardiomyopathy.

    abstract:BACKGROUND:The proinflammatory cytokines have been implicated in the pathogenesis of heart failure. Recent studies have shown that beta-adrenergic blockade can modulate cytokine production. This study investigates the different impact of different degrees of sympathetic antagonism on circulating levels of cytokines in ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.cardfail.2004.07.006

    authors: Cinquegrana G,D'Aniello L,Landi M,Spinelli L,Grande G,De Prisco F,Petretta M

    更新日期:2005-04-01 00:00:00

  • A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure.

    abstract:BACKGROUND:We sought to systematically combine the evidence on efficacy of disease management programs (DMPs) in the treatment of congestive heart failure (CHF), to identify and explain heterogeneity of results from prior studies of DMPs, and to assess potential publication bias from these studies. METHODS AND RESULTS...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析,评审

    doi:10.1016/j.cardfail.2006.03.003

    authors: Göhler A,Januzzi JL,Worrell SS,Osterziel KJ,Gazelle GS,Dietz R,Siebert U

    更新日期:2006-09-01 00:00:00

  • Relationship between anemia and health care costs in heart failure.

    abstract:BACKGROUND:Anemia is associated with higher morbidity and mortality in patients with heart failure (HF), but its implications for heath care costs are not well described. METHODS AND RESULTS:We analyzed data on 1056 patients with symptomatic HF seen at Duke University between 2002 and 2006. Health care costs were obta...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.06.435

    authors: Allen LA,Anstrom KJ,Horton JR,Shaw LK,Eisenstein EL,Felker GM

    更新日期:2009-12-01 00:00:00

  • Variability in the clinical status of patients with advanced heart failure.

    abstract:BACKGROUND:The importance of repeated clinical assessments of patients with heart failure is widely accepted. The frequency of such follow-up is not established and is likely to depend on the natural history and variability of patients' health status and the availability and use of appropriate treatments. METHODS AND ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.cardfail.2003.12.008

    authors: Hauptman PJ,Masoudi FA,Weintraub WS,Pina I,Jones PG,Spertus JA,Cardiovascular Outcomes Research Consortium.

    更新日期:2004-10-01 00:00:00

  • Extending the boundaries of cardiac resynchronization therapy: efficacy in atrial fibrillation, New York heart association class II, and narrow QRS heart failure patients.

    abstract:BACKGROUND:Large-scale clinical trials have demonstrated the benefits of cardiac resynchronization therapy (CRT) in patients with New York Heart Association (NYHA) Class III/IV heart failure, systolic left ventricular dysfunction, and a wide QRS. However, additional patient groups may also benefit from CRT. METHODS AN...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章,meta分析

    doi:10.1016/j.cardfail.2009.12.018

    authors: Wein S,Voskoboinik A,Wein L,Billah B,Krum H

    更新日期:2010-05-01 00:00:00

  • Effects of short-term forearm exercise training on resistance vessel endothelial function in normal subjects and patients with heart failure.

    abstract:BACKGROUND:Exercise training improves endothelium-dependent vasodilation in animals. This study was designed to determine whether forearm exercise training improves endothelium-dependent vasodilation in control subjects and patients with heart failure, a disease associated with abnormal endothelium-dependent vasodilati...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章

    doi:10.1016/s1071-9164(98)80006-7

    authors: Bank AJ,Shammas RA,Mullen K,Chuang PP

    更新日期:1998-09-01 00:00:00

  • Association of Wolff-Parkinson-White With Left Ventricular Noncompaction Cardiomyopathy in Children.

    abstract:BACKGROUND:Wolff-Parkinson-White (WPW) has been associated with left ventricular noncompaction (LVNC) in children. Little is known about the prevalence of this association, clinical outcomes, and treatment options. METHODS:Retrospective review of subjects with LVNC. LVNC was defined by established criteria; those with...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2019.09.014

    authors: Howard TS,Valdes SO,Hope KD,Morris SA,Landstrom AP,Schneider AE,Miyake CY,Denfield SW,Pignatelli RH,Wang Y,Kim JJ

    更新日期:2019-12-01 00:00:00

  • Did Frédéric Chopin Die From Heart Failure?

    abstract::On October 17, 1849, Poland's greatest composer, Frédéric Chopin (1810-1849) died aged 39. His cause of death remains unknown. An investigation of the documental sources was performed to reconstruct the medical history of the artist. Since his earliest years, his life had been dominated by poor health. Recurrent episo...

    journal_title:Journal of cardiac failure

    pub_type: 传,历史文章

    doi:10.1016/j.cardfail.2018.03.009

    authors: Perciaccante A,Charlier P,Negri C,Coralli A,Appenzeller O,Bianucci R

    更新日期:2018-05-01 00:00:00

  • Cardiac Adenylyl Cyclase and Phosphodiesterase Expression Profiles Vary by Age, Disease, and Chronic Phosphodiesterase Inhibitor Treatment.

    abstract:BACKGROUND:Pediatric heart failure (HF) patients have a suboptimal response to traditional HF medications, although phosphodiesterase-3 inhibition (PDE3i) has been used with greater success than in the adult HF population. We hypothesized that molecular alterations specific to children with HF and HF etiology may affec...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2016.07.429

    authors: Nakano SJ,Sucharov J,van Dusen R,Cecil M,Nunley K,Wickers S,Karimpur-Fard A,Stauffer BL,Miyamoto SD,Sucharov CC

    更新日期:2017-01-01 00:00:00

  • The usefulness of bioelectrical impedance analysis in differentiating dyspnea due to decompensated heart failure.

    abstract:BACKGROUND:Acute dyspnea poses a diagnostic challenge for physicians, and the current methods in differentiating cardiac from non-cardiac causes have been limited to date. Recently, the brain natriuretic peptide (BNP) rapid test has been validated in the emergency room. Nevertheless, the early accumulation of fluid in ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2008.04.005

    authors: Parrinello G,Paterna S,Di Pasquale P,Torres D,Fatta A,Mezzero M,Scaglione R,Licata G

    更新日期:2008-10-01 00:00:00

  • Effect of intravenous immunoglobulin for fulminant myocarditis on in-hospital mortality: propensity score analyses.

    abstract:BACKGROUND:Fulminant myocarditis (FM) is a rare but life-threatening disease. Intravenous immunoglobulin (IVIG) is not recommended for acute or chronic myocarditis in Western nations owing to the lack of rigorous evidence, but it is widely used in other countries, including Japan. This nationwide retrospective cohort s...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2015.01.004

    authors: Isogai T,Yasunaga H,Matsui H,Tanaka H,Horiguchi H,Fushimi K

    更新日期:2015-05-01 00:00:00

  • Can Biomarkers Provide Right Ventricular-Specific Prognostication in the Perioperative Setting?

    abstract::Since the introduction of biomarkers in the late 1980s, considerable research has been dedicated to their validation and application. As a result, many biomarkers are now commonly used in clinical practice. However, the role of biomarkers in the prediction of right ventricular failure (RVF) and in the prognostication ...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2019.09.007

    authors: Jabagi H,Ruel M,Sun LY

    更新日期:2020-09-01 00:00:00

  • Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group.

    abstract:BACKGROUND:Heart failure in blacks has been associated with a poorer prognosis than in whites. In such diseases as hypertension, blacks show pathophysiological differences and respond differently to some therapies than whites. The aim of this study is to evaluate the clinical characteristics and response to therapy of ...

    journal_title:Journal of cardiac failure

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s1071-9164(99)90001-5

    authors: Carson P,Ziesche S,Johnson G,Cohn JN

    更新日期:1999-09-01 00:00:00

  • Negative clinical outcomes associated with drug-related problems in heart failure (HF) outpatients: impact of a pharmacist in a multidisciplinary HF clinic.

    abstract:BACKGROUND:Drug-related negative outcomes (DNOs) are health problems that patients experience due to drug use or nonuse. Heart failure (HF) patients are at high risk of experiencing DNOs owing to polypharmacy, comorbidities, and age. METHODS AND RESULTS:Ninety-seven consecutive HF patients were enrolled and followed f...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2010.10.009

    authors: Gastelurrutia P,Benrimoj SI,Espejo J,Tuneu L,Mangues MA,Bayes-Genis A

    更新日期:2011-03-01 00:00:00

  • Functional electrical stimulation is more effective in severe symptomatic heart failure patients and improves their adherence to rehabilitation programs.

    abstract:BACKGROUND:Functional electrical stimulation (FES) improves exercise capacity and quality of life in chronic heart failure (CHF) patients. However, there is no evidence regarding the effectiveness of this treatment modality according to the severity of CHF. This study compares the effectiveness of FES on exercise capac...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2009.10.023

    authors: Karavidas A,Parissis JT,Matzaraki V,Arapi S,Varounis C,Ikonomidis I,Grillias P,Paraskevaidis I,Pirgakis V,Filippatos G,Kremastinos DT

    更新日期:2010-03-01 00:00:00

  • Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.

    abstract:BACKGROUND:Activated vitamin D analog, paricalcitol, has been shown to attenuate the development of cardiac hypertrophy in Dahl salt sensitive (DSS) rats. To determine whether an antihypertrophic effect is class specific, we tested if doxercalciferol (a pro-hormone vitamin D2 analog) could also attenuate the developmen...

    journal_title:Journal of cardiac failure

    pub_type: 杂志文章

    doi:10.1016/j.cardfail.2011.08.006

    authors: Choi JH,Ke Q,Bae S,Lee JY,Kim YJ,Kim UK,Arbeeny C,Thadhani R,Kang PM

    更新日期:2011-12-01 00:00:00